Literature DB >> 6176366

Latex immunoassay of retinol-binding protein.

A M Bernard, D Moreau, R R Lauwerys.   

Abstract

Latex immunoassay, a sensitive method based on latex particle agglutination, is used here for the determination of retinol-binding protein in human biological fluids. The assay, similar to that described previously for beta 2-microglobulin (Clin. Chem. 27:832-837, 1981), consists of incubating the sample at 37 degrees C for 30 min with antibody-coated particles, then quantifying the resulting agglutination by particle-counting or turbidimetry. Latex particles coated with antibody are stabilized just before use by dispersing them in a solution of bovine serum albumin at pH 10. The standard curve ranges from 0.5 to 32 micrograms/L; recovery averages 102% in urine and 93.5% in serum; between- and within-assay CVs range from 5.1 to 11.7%. The correlation coefficients of latex immunoassay with rocket immunoelectrophoresis for analysis of retinol-binding protein in 26 urines and with radial immunodiffusion in 30 sera are 0.99 and 0.91, respectively. In healthy subjects, the mean urinary excretion of retinol-binding protein is 52.5 micrograms/g of creatinine (SD = 59.2 micrograms/g of creatinine; n = 150) and the concentration in serum averages 46 mg/L (SD = 10.4 mg/L, n = 22).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176366

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human.

Authors:  P N MacDonald; D Bok; D E Ong
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Health surveillance of workers exposed to tetrachloroethylene in dry-cleaning shops.

Authors:  R Lauwerys; J Herbrand; J P Buchet; A Bernard; J Gaussin
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

3.  Urinary cadmium and lead concentrations and their relation to blood pressure in a population with low exposure.

Authors:  J Staessen; C J Bulpitt; H Roels; A Bernard; R Fagard; J V Joossens; R Lauwerys; P Lijnen; A Amery
Journal:  Br J Ind Med       Date:  1984-05

4.  Occupational exposure to cadmium and kidney dysfunction.

Authors:  M Jakubowski; B Trojanowska; G Kowalska; E Gendek; Z Starzyński; B Krajewska; J Jajte
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

Review 5.  Low molecular weight proteins in children with renal disease.

Authors:  P A Tomlinson
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

Review 6.  Assessment of retinol-binding protein excretion in normal children.

Authors:  G C Smith; M H Winterborn; C M Taylor; N Lawson; M Guy
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Analysis of the renal tissue of a woman chronically exposed to cadmium.

Authors:  M Cikrt; J Hurych; D Kuklová; J Havrdová; P Lepsí; J Kopecký; B Málek; A Naus
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

8.  Development of a multiplex mass spectrometry method for simultaneous quantification of urinary proteins related to respiratory health.

Authors:  Sarah J D Nauwelaerts; Nancy H C Roosens; Alfred Bernard; Sigrid C J De Keersmaecker; Koen De Cremer
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

9.  In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine.

Authors:  Mohammad Ahmad Mahmoud; Doaa Ahmad Ghareeb; Heba Abdelghany Sahyoun; Ashraf Abdelhamed Elshehawy; Mohammad Mohammad Elsayed
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-24       Impact factor: 2.629

10.  The physiological determinants of low-level urine cadmium: an assessment in a cross-sectional study among schoolchildren.

Authors:  Hongyu Wang; Xavier Dumont; Vincent Haufroid; Alfred Bernard
Journal:  Environ Health       Date:  2017-09-12       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.